Robin Kämpe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robin Kämpe has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- J. Paul Hamilton
Department of Biological and Medical Psychology, University of Bergen, 5020 Bergen, Norway
3 shared publications - Irene Perini
Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
2 shared publications - Markus Heilig
Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
2 shared publications - Adam Yngve
Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
1 shared publication - Alana Brown
Department of Psychology University of Toronto Toronto Ontario Canada
1 shared publication - Anders Eklund
Department of Biomedical Engineering, Linköping University, Linköping, Sweden
1 shared publication
Latest Publications
- Open Access
- 25 February 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (7) , 1237-1244
The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder
The Neural Craving Signature (NCS), a machine learning derived neuroimaging biomarker, differentiates individuals with from those without substance use disorders (SUDs), but has not been evaluated for predicting clinical outcomes. In a secondary analysis, we applied the NCS to fMRI cue-reactivity data from 39 participants in a published, negative RCT of repetitive transcranial magnetic stimulation (rTMS) for Alcohol Use Disorder (AUD). NCS scores predicted craving [Penn Alcohol Craving Scale (PACS)], both at the time of fMRI ( R 2 = 0.29, 95%, CI [0.27, 0.73], t(36) = 3.86, p = 0.0005), and during repeated study visits (β = 4.6, SE = 5.3, t(39.15) = 1.17, p < 0.0001). NCS also classified AUD severity (Addiction Severity Index, ASI, alcohol subscale—β = 0.14, SE = 0.04, p = 0.0016, R² = 0.24; Alcohol Use Disorder Identification Test, AUDIT, β = 5.32, SE = 1.46, p < 0.0025, R² = 0.22). Most importantly, the NCS predicted alcohol use, both measured by self-reported percent heavy drinking days (HDD%; β = 10.19, SE = 4.46, t(38.23) = 2.28, p = 0.028) and the biomarker phosphatidyl ethanol (PEth; β = 0.32, SE = 0.15, t(37.10) = 2.15, p = 0.038). Participants with below median NCS scores had a lower likelihood of relapse than those above median (Cox regression—HR = 0.35, 95% CI [0.16–0.80], p = 0.013). NCS identified relapse cases with an area under the curve of 0.79 (SE = 0.077, z = 3.8, p = 0.0001), achieving 66.7% sensitivity and 77.8% specificity at optimal NCS score. These findings provide initial support for the NCS as a predictor of clinical outcomes in AUD.
- 25 February 2026
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (7) , 1237-1244
Open AccessThe neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder
The Neural Craving Signature (NCS), a machine learning derived neuroimaging biomarker, differentiates individuals with from those without substance use disorders (SUDs), but has not been evaluated for predicting clinical outcomes. In a secondary analysis, we applied the NCS to fMRI cue-reactivity data from 39 participants in a published, negative RCT of repetitive transcranial magnetic stimulation (rTMS) for Alcohol Use Disorder (AUD). NCS scores predicted craving [Penn Alcohol Craving Scale (PACS)], both at the time of fMRI ( R 2 = 0.29, 95%, CI [0.27, 0.73], t(36) = 3.86, p = 0.0005), and during repeated study visits (β = 4.6, SE = 5.3, t(39.15) = 1.17, p < 0.0001). NCS also classified AUD severity (Addiction Severity Index, ASI, alcohol subscale—β = 0.14, SE = 0.04, p = 0.0016, R² = 0.24; Alcohol Use Disorder Identification Test, AUDIT, β = 5.32, SE = 1.46, p < 0.0025, R² = 0.22). Most importantly, the NCS predicted alcohol use, both measured by self-reported percent heavy drinking days (HDD%; β = 10.19, SE = 4.46, t(38.23) = 2.28, p = 0.028) and the biomarker phosphatidyl ethanol (PEth; β = 0.32, SE = 0.15, t(37.10) = 2.15, p = 0.038). Participants with below median NCS scores had a lower likelihood of relapse than those above median (Cox regression—HR = 0.35, 95% CI [0.16–0.80], p = 0.013). NCS identified relapse cases with an area under the curve of 0.79 (SE = 0.077, z = 3.8, p = 0.0001), achieving 66.7% sensitivity and 77.8% specificity at optimal NCS score. These findings provide initial support for the NCS as a predictor of clinical outcomes in AUD.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Hippocampal function during an associative memory task is influenced by early bilateral salpingo‐oophorectomy
Background: Women with mid‐life 17β‐estradiol loss due to early bilateral salpingo‐oophorectomy (BSO; removal of ovaries and fallopian tubes) have heightened Alzheimer’s disease (AD) risk (Rocca et al., 2007). 17β‐estradiol loss is related to AD risk factors, including associative memory decrements and decreased functional magnetic resonance imaging (fMRI)‐measured hippocampal activation during encoding (Jacobs et al., 2016; Rentz et al., 2017). Our objective was to investigate the effects of early BSO and 17β‐estradiol replacement therapy (ERT) on associative memory and hippocampal function.Method: Women with BSO either taking ERT (BSO+ERT; M±SEage= 45±1.03, n = 23) or not taking ERT (BSO; M±SEage= 45.7±1.01, n = 23) were compared to age‐matched premenopausal control women (AMC; M±SEage= 43.7±0.48, n = 37) on fMRI‐measured brain activation during encoding and retrieval trials of a face‐name associative memory task. We compared groups on activation from anterior and posterior anatomical hippocampal regions‐of‐interest during retrieval and encoding (retrieval‐encoding contrast) trials between groups. We also compared hippocampal activation during novel and repeat face‐name pair encoding trials (novel‐repeat encoding contrast). Face‐name pair recognition accuracy between groups was also assessed.Result: Compared to BSO+ERT, BSO exhibited significantly lower activation during novel compared to repeat encoding trials (Fig.1A) in the right anterior hippocampal region‐of‐interest (Fig.1B). There were no significant group differences in hippocampal activation during retrieval compared to encoding trials, and no group differences in recognition accuracy.Conclusion: Younger women with BSO either taking ERT or not showed comparable hippocampal activation to age‐matched premenopausal women during retrieval of face‐name pairs. However, during encoding of face‐name pairs, BSO showed significantly lower right anterior hippocampal activation compared to BSO+ERT. ERT may influence associative encoding processes dependent on hippocampal novelty detection, rather than retrieval processes. Expanding on work from others (Phillips & Sherwin, 1992), these results suggest ERT may ameliorate the negative influence of oophorectomy on hippocampal‐dependent memory processes.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessHippocampal function during an associative memory task is influenced by early bilateral salpingo‐oophorectomy
Background: Women with mid‐life 17β‐estradiol loss due to early bilateral salpingo‐oophorectomy (BSO; removal of ovaries and fallopian tubes) have heightened Alzheimer’s disease (AD) risk (Rocca et al., 2007). 17β‐estradiol loss is related to AD risk factors, including associative memory decrements and decreased functional magnetic resonance imaging (fMRI)‐measured hippocampal activation during encoding (Jacobs et al., 2016; Rentz et al., 2017). Our objective was to investigate the effects of early BSO and 17β‐estradiol replacement therapy (ERT) on associative memory and hippocampal function.Method: Women with BSO either taking ERT (BSO+ERT; M±SEage= 45±1.03, n = 23) or not taking ERT (BSO; M±SEage= 45.7±1.01, n = 23) were compared to age‐matched premenopausal control women (AMC; M±SEage= 43.7±0.48, n = 37) on fMRI‐measured brain activation during encoding and retrieval trials of a face‐name associative memory task. We compared groups on activation from anterior and posterior anatomical hippocampal regions‐of‐interest during retrieval and encoding (retrieval‐encoding contrast) trials between groups. We also compared hippocampal activation during novel and repeat face‐name pair encoding trials (novel‐repeat encoding contrast). Face‐name pair recognition accuracy between groups was also assessed.Result: Compared to BSO+ERT, BSO exhibited significantly lower activation during novel compared to repeat encoding trials (Fig.1A) in the right anterior hippocampal region‐of‐interest (Fig.1B). There were no significant group differences in hippocampal activation during retrieval compared to encoding trials, and no group differences in recognition accuracy.Conclusion: Younger women with BSO either taking ERT or not showed comparable hippocampal activation to age‐matched premenopausal women during retrieval of face‐name pairs. However, during encoding of face‐name pairs, BSO showed significantly lower right anterior hippocampal activation compared to BSO+ERT. ERT may influence associative encoding processes dependent on hippocampal novelty detection, rather than retrieval processes. Expanding on work from others (Phillips & Sherwin, 1992), these results suggest ERT may ameliorate the negative influence of oophorectomy on hippocampal‐dependent memory processes.
- Open Access
- 23 December 2023
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 9 (4) , 437-446
Contributions of Polygenic Risk and Disease Status to Gray Matter Abnormalities in Major Depression
- 23 December 2023
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 9 (4) , 437-446
Open AccessContributions of Polygenic Risk and Disease Status to Gray Matter Abnormalities in Major Depression
- Open Access
- 15 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1329
Efficient Brain Age Prediction from 3D MRI Volumes Using 2D Projections
Using 3D CNNs on high-resolution medical volumes is very computationally demanding, especially for large datasets like UK Biobank, which aims to scan 100,000 subjects. Here, we demonstrate that using 2D CNNs on a few 2D projections (representing mean and standard deviation across axial, sagittal and coronal slices) of 3D volumes leads to reasonable test accuracy (mean absolute error of about 3.5 years) when predicting age from brain volumes. Using our approach, one training epoch with 20,324 subjects takes 20–50 s using a single GPU, which is two orders of magnitude faster than a small 3D CNN. This speedup is explained by the fact that 3D brain volumes contain a lot of redundant information, which can be efficiently compressed using 2D projections. These results are important for researchers who do not have access to expensive GPU hardware for 3D CNNs.
- 15 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1329
Open AccessEfficient Brain Age Prediction from 3D MRI Volumes Using 2D Projections
Using 3D CNNs on high-resolution medical volumes is very computationally demanding, especially for large datasets like UK Biobank, which aims to scan 100,000 subjects. Here, we demonstrate that using 2D CNNs on a few 2D projections (representing mean and standard deviation across axial, sagittal and coronal slices) of 3D volumes leads to reasonable test accuracy (mean absolute error of about 3.5 years) when predicting age from brain volumes. Using our approach, one training epoch with 20,324 subjects takes 20–50 s using a single GPU, which is two orders of magnitude faster than a small 3D CNN. This speedup is explained by the fact that 3D brain volumes contain a lot of redundant information, which can be efficiently compressed using 2D projections. These results are important for researchers who do not have access to expensive GPU hardware for 3D CNNs.
- Open Access
- 15 June 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (12)
A randomized controlled experimental medicine study of ghrelin in value-based decision making
BACKGROUND. The stomach-derived hormone ghrelin stimulates appetite, but the ghrelin receptor is also expressed in brain circuits involved in motivation and reward. We examined ghrelin effects on decision making beyond food or drug reward using monetary rewards. METHODS. Thirty participants (50% women and 50% men) underwent 2 fMRI scans while receiving i.v. ghrelin or saline in a randomized counterbalanced order. RESULTS. Striatal representations of reward anticipation were unaffected by ghrelin, while activity during anticipation of losses was attenuated. Temporal discounting rates of monetary reward were lower overall in the ghrelin condition, an effect driven by women. Discounting rates were inversely correlated with neural activity in a large cluster within the left parietal lobule that included the angular gyrus. Activity in an overlapping cluster was related to behavioral choices and was suppressed by ghrelin. CONCLUSION. This is, to our knowledge, the first human study to extend the understanding of ghrelin’s significance beyond the canonical feeding domain or in relation to addictive substances. Contrary to our hypothesis, we found that ghrelin did not affect sensitivity to monetary reward anticipation, but rather resulted in attenuated loss aversion and lower discounting rates for these rewards. Ghrelin may cause a motivational shift toward caloric reward rather than globally promoting the value of reward. TRIAL REGISTRATION. EudraCT 2018-004829-82. FUNDING. Swedish Research Council (2013-07434), Marcus and Marianne Wallenberg foundation (2014.0187) and National Institute on Drug Abuse/National Institute on Alcohol Abuse and Alcoholism Intramural Research Program.
- 15 June 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (12)
Open AccessA randomized controlled experimental medicine study of ghrelin in value-based decision making
BACKGROUND. The stomach-derived hormone ghrelin stimulates appetite, but the ghrelin receptor is also expressed in brain circuits involved in motivation and reward. We examined ghrelin effects on decision making beyond food or drug reward using monetary rewards. METHODS. Thirty participants (50% women and 50% men) underwent 2 fMRI scans while receiving i.v. ghrelin or saline in a randomized counterbalanced order. RESULTS. Striatal representations of reward anticipation were unaffected by ghrelin, while activity during anticipation of losses was attenuated. Temporal discounting rates of monetary reward were lower overall in the ghrelin condition, an effect driven by women. Discounting rates were inversely correlated with neural activity in a large cluster within the left parietal lobule that included the angular gyrus. Activity in an overlapping cluster was related to behavioral choices and was suppressed by ghrelin. CONCLUSION. This is, to our knowledge, the first human study to extend the understanding of ghrelin’s significance beyond the canonical feeding domain or in relation to addictive substances. Contrary to our hypothesis, we found that ghrelin did not affect sensitivity to monetary reward anticipation, but rather resulted in attenuated loss aversion and lower discounting rates for these rewards. Ghrelin may cause a motivational shift toward caloric reward rather than globally promoting the value of reward. TRIAL REGISTRATION. EudraCT 2018-004829-82. FUNDING. Swedish Research Council (2013-07434), Marcus and Marianne Wallenberg foundation (2014.0187) and National Institute on Drug Abuse/National Institute on Alcohol Abuse and Alcoholism Intramural Research Program.
- Open Access
- 15 March 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (3) , 794-810
Prediction and action in cortical pain processing
Predicting that a stimulus is painful facilitates action to avoid harm. But how distinct are the neural processes underlying the prediction of upcoming painful events vis-à-vis those taking action to avoid them? Here, we investigated brain activity as a function of current and predicted painful or nonpainful thermal stimulation, as well as the ability of voluntary action to affect the duration of upcoming stimulation. Participants performed a task which involved the administration of a painful or nonpainful stimulus (S1), which predicted an immediately subsequent very painful or nonpainful stimulus (S2). Pressing a response button within a specified time window during S1 either reduced or did not reduce the duration of the upcoming stimulation. Predicted pain increased activation in several regions, including anterior cingulate cortex (ACC), midcingulate cortex (MCC), and insula; however, activation in ACC and MCC depended on whether a meaningful action was performed, with MCC activation showing a direct relationship with motor output. Insula’s responses for predicted pain were also modulated by potential action consequences, albeit without a direct relationship with motor output. These findings suggest that cortical pain processing is not specifically tied to the sensory stimulus, but instead, depends on the consequences of that stimulus for sensorimotor control of behavior.
- 15 March 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (3) , 794-810
Open AccessPrediction and action in cortical pain processing
Predicting that a stimulus is painful facilitates action to avoid harm. But how distinct are the neural processes underlying the prediction of upcoming painful events vis-à-vis those taking action to avoid them? Here, we investigated brain activity as a function of current and predicted painful or nonpainful thermal stimulation, as well as the ability of voluntary action to affect the duration of upcoming stimulation. Participants performed a task which involved the administration of a painful or nonpainful stimulus (S1), which predicted an immediately subsequent very painful or nonpainful stimulus (S2). Pressing a response button within a specified time window during S1 either reduced or did not reduce the duration of the upcoming stimulation. Predicted pain increased activation in several regions, including anterior cingulate cortex (ACC), midcingulate cortex (MCC), and insula; however, activation in ACC and MCC depended on whether a meaningful action was performed, with MCC activation showing a direct relationship with motor output. Insula’s responses for predicted pain were also modulated by potential action consequences, albeit without a direct relationship with motor output. These findings suggest that cortical pain processing is not specifically tied to the sensory stimulus, but instead, depends on the consequences of that stimulus for sensorimotor control of behavior.